# A Pilot Study of Inflammatory Markers in Alzheimer's Disease

> **NCT00715858** · PHASE3 · UNKNOWN · sponsor: **McMaster University** · enrollment: 21 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** doxycycline
- **DRUG:** rifampin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00715858
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2009-08
- **Final completion:** 2009-10
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2009-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00715858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00715858, "A Pilot Study of Inflammatory Markers in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00715858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*